Physician profile
Christopher Malone
NPI 1114303443
$33,898.94
in general payments reported to CMS, 2019-2025
15 companies · $319 in 2025
The $319 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,068 · 2020: $21K · 2021: $6,960 · 2022: $1,315 · 2023: $842 · 2024: $1,624 · 2025: $319.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,408 · Travel and Lodging: $1,356 · Education: $21.37.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,408.44 |
| Travel and Lodging | $1,355.77 |
| Education | $21.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $15,588.19 | 2020-2024 | |
| Smith+Nephew, INC. | $4,298.86 | 2020-2024 | Bioinductive Implant With Arthroscopic Delivery System - Medium, Speedscrew, Spatial Frame |
| Rock Medical Orthopedics, INC. | $4,010.11 | 2019-2020 | |
| Cdc Medical LLC | $3,927.20 | 2021-2024 | |
| Alon Medical Technology | $3,010.78 | 2020-2021 | |
| Pacira Pharmaceuticals Incorporated | $1,213.36 | 2021-2025 | Iovera, Exparel, Zilretta |
| Medical Device Business Services, INC. | $621.53 | 2021 | |
| Zimmer Biomet Holdings, INC. | $489.78 | 2022-2025 | Identity, Rosa, Persona |
| Stryker Corporation | $377.67 | 2021-2025 | Aequalis Flex Revive, Blueprint Patient Specific Instrumentation, Aequalis Perform+ |
| Vericel Corporation | $145.93 | 2021-2023 | Maci |
| Depuy Synthes Sales INC. | $103.00 | 2021 | |
| Globus Medical, INC. | $34.77 | 2024 | Legacy Stelkast Knee, Onvoy |
| Omnilife Science, INC | $32.89 | 2024 | Various Products |
| Pacira Therapeutics, INC. | $28.33 | 2020 | |
| Anika Therapeutics, INC. | $16.54 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Malone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.